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ABSTRACT

Jenseniin P, a bacteriocin discovered by Prince, can inhibit the growth of
several strains of propionibacteria and lactobacillus(Prince 1993). Ratnam further
purified jenseniin P by ammonia sulfate precipitation and anion exchange
chromatography. In that study, partially purified jenseniin P was stable in various pH
ranges, SDS concentrations, several solvents, and remained active after holding at
100 °C for 60 minutes. The molecular weight was estimated to be between 6 and 9
kDa.

In

addition,

jenseniin

P was

demonstrated

to

be

inhibitory to

Propionibacterium acnes using the spot-on-lawn method. Thus, Ratnam postulated
its possible application in acne treatment(Ratnam 1997).
In this present work, jenseniin P was further purified using C18 resin silica
column. Vivaspin and ammonia sulfate precipitation methods were also evaluated.
This further purified jenseniin P was inactivated by trypsin, pronase, and protease K,
which confirmed its proteinaceous nature. The molecular weight of jenseniin P was
further narrowed down to be between 4.5 and 5kDa. Jenseniin P was characterized
to be pH stable and heat stable using a microtiter plate method developed in this
work, which was 8-fold more sensitive than the previous critical dilution method
described by Ratnam. The mode of action of jenseniin P was determined to be
bactericidal with a killing rate of 2.38 log h-1.

We also detected a new agent produced by Propionibacterium jensenii B1264
that inhibited the growth of Propionibacterium acnes 6919 but not Lactobacillus
delbrueckii subsp. lactis ATCC 4797, the indicator strain used in previous studies.
This inhibitory agent was recovered from the 30% acetonitrile elution fraction of
C18 resin silica column purification process, which was different from the
previously reported jenseniin P, because the jenseniin P that inhibited the growth of
L. delbrueckii subsp. lactis ATCC 4797 was mostly recovered from the 50%
acetonitrile elution fraction. This P. acnes specific inhibitory agent is currently being
investigated.
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CHAPTER ONE

LITERATURE REVIEW

1.1 Bacteriocin

1.1.1 General Characteristics of Bacteriocin

Antimicrobial peptides are produced by various kinds of organisms(Faye,
Brede et al. 2002). Multiple antimicrobial peptides have been isolated from different
organisms, such as mammals(Lehrer, Lichtenstein et al. 1993), amphibians(Zasloff
1987), fish(Cole, Weis et al. 1997), insects(Steiner, Hultmark et al. 1981),
plants(Cammue, De Bolle et al. 1992), and different microorganisms(Jack, Tagg et
al. 1995). In 1925, Gratia demonstrated that strain V of Escherichia coli can produce
a dialyzable and heat-stable antimicrobial agent that inhibits the growth of E. coli ɸ,
which was later named colicin V(Gratia 1925; Jack, Tagg et al. 1995). A whole
series of colicins produced by E. coli and closely related members of the
Enterobacteriaceae were discovered afterward. To date, most of the significant
progress in bacteriocin research stemmed from study of the colicins, and this
resulted in considerable in-depth knowledge of the genetic basis, domain structure,
mode of formation, and inhibitory action of bacteriocins(Cotter, Hill et al. 2005).
By definition, bacteriocins are gene-encoded, ribosomally-synthesized proteins
or peptides that usually display antimicrobial activity against species closely related
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to the producer strains(Brede, Faye et al. 2004). Many bacteriocins produced by
Gram-positive bacteria have been isolated and characterized(Faye, Brede et al.
2002), and most characterized bacteriocins thus far show a narrow spectrum of
inhibition(Faye, Langsrud et al. 2000). However, there are exceptions. For example,
some bacteriocins produced by lactic acid bacteria (LAB), such as nisin, inhibit not
only closely related species but also food-borne pathogens such as Listeria
monocytogenes and many other Gram-positive spoilage microorganisms.

1.1.2 Bacteriocins and Antibiotics

Even though both bacteriocin and antibiotics have antimicrobial activity and
can be produced by bacteria, there are several differences between them. First,
bacteriocins are synthesized via ribosome, while antibiotics are synthesized by
enzymatic systems; Second, bacteriocins usually have a narrow spectrum of
inhibition, while in general antibiotics have a much broader spectrum; Third, the
gene that encodes the immunity protein of bacteriocin is always linked to the
structure gene that encodes the bacteriocin, while the gene that determines antibiotic
resistance is usually independent from the genes that encode the antibiotic synthesis
apparatus(Dutton 2002). Antimicrobial peptides produced by bacteria are not
necessarily bacteriocins. For example, the broad spectrum antimicrobial bacitracin is
not a bacteriocin because its biosynthesis is carried out non-ribosomally by
bacitracin synthetase ABC, a multi-enzyme complex(Froyshov 1977).
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1.1.3 Classification of Bacteriocins Produced by LAB

The most thoroughly studied bacteriocins are bacteriocins produced by LAB
because a wide variety of strains are routinely utilized as starter cultures in the
manufacture of meat, dairy, and vegetable products(O'Sullivan, Ross et al. ; Nettles
and Barefoot 1993). They cause rapid acidification of the raw material through the
production of organic acids, mainly lactic acids. In addition, their production of
ethanol, aroma compounds, bacteriocins, exopolysaccharides, and several enzymes
are of great value in food fermentation and safety.
It has been estimated that 3%-99% of bacteria and archaea can produce more
than one bacteriocin; many of the reported bacteriocins are produced by
LAB(Klaenhammer 1988). These bacteriocins are the most investigated and studied
because they have immediate potential in food applications without being
thoroughly purified. In 1993, based on common characteristics and structure,
Klaenhammer proposed to classify all the discovered lactic acid bacteriocins into
three main groups: Class I, II and III bacteriocins (Table 1) (Klaenhammer 1993;
Nes, Diep et al. 1996)
Class I is composed of small, post-translationally modified peptides that are
characterized by the presence of modified thioether amino acids and α-,
β-unsaturated amino acids and are usually referred to as lantibiotics (Twomey, Ross
et al. 2002). Class II is composed of a large group of heat-stable, unmodified peptide
bacteriocins which can also be further subdivided to Class IIa, Class IIb and Class
3

IIc(Ennahar, Sonomoto et al. 1999). Class III bacteriocin consists of large, and
heat-labile bacteriocins(Nes, Diep et al. 1996)
Table 1.1 Classification of LAB bacteriocin

This table was reproduced with permission(Drider, Fimland et al. 2006), APPENDIX.

1.1.4 Applications of Bacteriocins

In recent years, there has been a significant focus on bacteriocins produced by
Gram-positive bacteria. Many of these bacteriocins are food grade organisms that
are already commonly used in food industry but now offer the further prospect of
application to improve food preservation. Another contributing factor has been the
burgeoning interest in possible applications of bacterial interference as a strategy for
the prevention of certain infectious diseases(O'Sullivan, Ross et al.). In this present
work, a bacteriocin produced by propionibacteria was studied. Examples of
application of bacteriocins are described as follows:
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First, bacteriocins can be used to enhance food quality. For example, a cheese
made with a commercial starter culture that does not produce lacticin 3147 develops
an undefined microflora while a cheese inoculated with the same commercial strain
that produces lacticin 3147 and a resistant adjunct strain of lactobacillus, develops a
single defined culture once the starter culture has died off, enabling the cheese
manufacturer to control flora development (Fig 3a).
Second, bacteriocins may be produced directly in the food as a result of starter
culture or co-culture activity[2]. Several studies have indeed indicated that LAB
starter cultures or co-cultures are able to produce bacteriocins in food matrices, thus
exhibiting inhibitory activity against sensitive food spoilage or pathogenic bacteria[2,
13]. A simple example of the usage of bacteriocins in food safety is the production
of cottage cheese with a starter culture that produces a bacteriocin with activity
against Listeria monocytogenes (Fig 3b).
Third, bacteriocins may be applied in veterinary medicine. For example, if a
bacteriocin was incorporated into the teat seal and the teat was challenged with
Staphylococcus aureus, the number of staphylococci recovered from 14 teats with
bacteriocin is remarkably lower than those without bacteriocin (Fig 3c).
Fourth, the bacteriocin may be used to develop human medicine. A
Streptococcus mutans strain that produces the lantibiotic mutacin, competitively
excludes acidogenic S. mutans, thereby offering protection against tooth decay (Fig
3d).

5

Figure 1.1 Selected applications of bacteriocins
This figure was reproduced with permission(Cotter, Hill et al. 2005), APPENDIX.

1.2 Propionibacterium

1.2.1 General Characteristics of Propionibacterium

According to Bergey’s Manual of Determinative Bacteriology, 9th Edition,
propionibacteria are non-filamentous pleomorphic rods, often clubshaped with one
end rounded and other end tapered. Some of the cells might be bifid, coccoid or
branched. Cells singly occur in short chains or pairs, in V or Y configurations or
Chinese characters(Bergey and Holt 1994). They are nonmotile and nonsporing
Gram-positive bacteria. They are facultative anaerobes, but most of them can grow
somewhat in air, while better in anaerobic environment. They are found mainly in
6

cheese and dairy products fermentation producing large amounts of propionic and
acetic acids and often small amount of gas. Based on their habitat, propionibacteria
are divided into two groups, i.e., the classical propionibacteria and the cutaneous
propionibacteria(Bergey and Holt 1994).

1.2.2 Classification of Propionibacterium

There are substantial differences between the two classes of propionibacteria.
Classical propionibacteria were commonly found in dairy products, soil and olive
fermentations. They can form eyes in Swiss chess because of CO2 production and
can produce vitamin B12 as well as propionic acid and bacteriocins(Vorobjeva 1999).
The typical species are P. freudenreichii, P. jensenii, P. thoenii, P. acidipropionici,
and P. cyclohexanicum(Vorobjeva 1999). The G+C content of classical
propionibacteria is 65-67%. The second class is cutaneous propionibacteria, which
typically includes P. acnes, P. avidum, P. granulosum, and P. lymphophilum. P. acnes
is the major pathogen that causes inflammation in acne development(Yates 2005).
The G+C content of cutaneous propionibacteria is 53-62%(Vorobjeva 1999).

1.2.3 Bacteriocins Produced by Propionibacteria

Many bacteriocins produced by propionibacteria have been described such as
propionicin A produced by P. freudenreichii(Ramanathan, Wolynec et al. 1968),
propionicin PLG-1 produced by P. thoenii P127(Lyon and Glatz 1991), but only four
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are characterized on a molecular level. They are propionicin SM1 produced by P.
jensenii DF1(Miescher, Stierli et al. 2000), propionicin T1 produced by P.
thoenii(Faye, Langsrud et al. 2000), a precursor protein of an antimicrobial peptide
(PAMP) produced by P. jensenii LMG3032(Faye, Brede et al. 2002), and
propionicin F produced by P. freudenreichii(Brede, Faye et al. 2004). All of these
four bacteriocins bacteriocins are initially synthesized as prebacteriocin first and
then modified by different enzymes to form mature bacteriocins. These two
characteristics are similar to those of the Class IIa bacteriocins produced by
LAB(Drider, Fimland et al. 2006). The most recent characterized one was
propionicin F. There are ten open reading frames (ORF) in the gene cluster, where
prebacteriocin,

protease,

transposase

and

ABC

transporter

proteins

are

synthesized(Brede, Faye et al. 2004).

1.3 Acne

Common acne or acne vulgaris is a chronic inflammation of the sebaceous
follicles that affects 85-100% of those aged 12-24(Burton, Cunliffe et al. 1971;
Bershad 2001). The comedo, a plug of sebum and keratin lodged in the follicular
duct, is its primary lesion. Comedones appear clinically as blackheads and
whiteheads. It may persist in some individuals to later years. Although symptoms
resolve in most individuals by the time they are 23 to 25 years of age, 1% of men
and 5% of women still are affected at age 40(Cunliffe and Gould 1979). Although
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not life-threatening, acne causes psychological and social distress and can cause
profound scarring and disfiguring with adverse long term social consequences.
Concern about acne is the most frequent reason that teenagers consult a
physician(Goodman 1999).

1.3.1 Acne Pathogenesis

Three underlying factors are implicated in human acne. They include (1)
increased secretion of sebum, an event controlled by genetic factors and stimulated by
androgenic hormones, (2) excess formation of keratin resulting in plugging of the
sebaceous duct, through which the sebaceous gland empties sebum into the sebaceous
follicle and (3) growth of P. acnes. P. acnes is believed to play a pivotal role in
converting mild acne to inflammatory acne (Table 1.2)(Bershad 2001; Dessinioti and
Katsambas 2010).
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Table 1.2 Data on the mechanism of action of P. acnes in acne pathogenesis

This table was reproduced with permission (Dessinioti and Katsambas 2010),
APPENDIX.

1.3.2 Current Treatments of Acne

Acne is a chronic disorder and its response to treatment is relatively slow.
Logical approaches for treatment of acne require targeting the above aetiological
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factors are listed as following(Yates 2005).
Table 1.3 Current treatments of acne(Dessinioti and Katsambas 2010)
Aetiological factors

Treatment

sebaceous gland blockage

retinoid and benzoyl peroxide

bacterial colonization
seborrhoea

antibiotics, benzoyl peroxide, azelaic acid

isotretinoin, retinoid, antibiotics

1.3.3 Bacteriocin Inhibition of P. acnes

P. acnes have been routinely treated by antibiotics, but antibiotic resistance is
an emerging problem in recent years(Yates 2005). Treating acnes with bacteriocins
might be an alternative choice for avoiding antibiotic resistance. One bacteriocin,
ESL5, produced in the supernatant of Enterococcus faecalis SL-5, showed
antimicrobial activity against numbers of Gram-positive pathogens, especially P.
acnes. In addition, cell-free culture supernatant of E. faecalis SL-5 was incorporated
into a lotion for application on the patients in one clinic trial. The lotion with this
bacteriocin significantly reduced the inflammatory lesions in mild to moderate acne
because of its inhibition against P. acnes(Kang, Seo et al. 2009).

1.4 Previous Studies of Jenseniin P

In 1993, Prince obtained eight dairy cultures from The All Union Collection of
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Microorganisms in Moscow and examined them for acid-unrelated inhibition of 62
Gram-positive and Gram-negative bacterial strains by the deferred agar spot-on-lawn
detection methods(Prince 1993). The results showed that P. jensenii P126, inhibited
itself, P. acidipropionici P5, P. jensenii P126, P. thoenii P127, P. species P1262 and
P1263, L. delbrueckii ssp. lactis ATCC 4797, L. delbrueckii ssp. lactis ATCC 9649, L.
bulgaricus NC1489 and L. acidophilus ATCC 4357. Among all the tested strains, L.
delbrueckii ssp. lactis ATCC 4797, from here on referred to as L. delbrueckii, was the
most sensitive strain. The inhibitory agent(s) was concluded by Prince to be a
bacteriocin and was named jenseniin P(Prince 1993).
In 1997, Ratnam partially purified the jenseniin P by ammonium sulfate
precipitation at 70% saturation and by batch anion exchange chromatography.
Jenseniin P was characterized to be heat-stable, pH-stable, and bactericidal in her
study. In that purification and characterization, L. delbrueckii was used as the
indicator strain. In addition, Ratnam reported for the first time that jenseniin P, a third
bacteriocin produced by dairy propionibacteria, was also an anti-acne bacteriocin that
could inhibit the growth of P. acnes(Ratnam 1997). In her study, Ratnam presumed
that the bacteriocin that inhibited the growth of P. acne to be the same one that
inhibited the growth of L. delbrueckii.

1.5 Objectives

The primary objective of this research is to further purify jensenii P. The second
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objective is to confirm the proteinaceous nature of jenseniin P, determine its
molecular weight, mode of action and test its pH and heat stability. The third
objective is to determine whether the bacteriocin that inhibits the growth of L.
delbrueckii is the same agent that inhibits the growth of P. acnes 6919.
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CHAPTER TWO

FURTHER PURIFICATION OF JENSENIIN P

2.1 Introduction

Bacteriocins are antimicrobial proteins or peptides. Hence, most bacteriocins
have been purified using various combined protein purification methods. The four
genetically characterized bacteriocins produced by propionibacteria were purified in
this manner with variations, depending on the characteristics of the bacteriocins.
Propionicin SM1, a bacteriocin produced by P. jensenii DF1, was purified first
by cation-exchange column and second by gel filtration column. After several
rounds of purification using these two methods, the sample was subjected to
SDS-PAGE electrophoresis. The separated

bands were transferred to a

polyvinylidene difluoride ImmobilonTM membrane. After electroblotting, the
transferred propionicin was detected by protein staining. The protein was sequenced
with gas-phase sequencing(Miescher, Stierli et al. 2000).
PAMP, produced by P. jensenii LMG3032, was precipitated by 40% ammonium
sulfate (wt/vol) followed by a 3 ml cation-exchange column and by gel filtration
column(Faye, Brede et al. 2002).
Propionicin T1, a bacteriocin from P. thoenii was first precipitated from the
supernatant by the addition of 40% ammonium sulfate and then purified by a cation
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exchange column followed by a reversed-phase chromatography(Faye, Langsrud et
al. 2000).
Propionicin F, a bacteriocin produced by P. freudenreichii LMGT2946 was
precipitated from the supernatant with 40% ammonium sulfate and then purified by
an anion-exchange column followed by a reverse phase chromatography(Brede,
Faye et al. 2004). In further details, the sample was applied onto the RESOURCE
RPC 1 ml column first, followed by application onto a Source 5RPC ST 4.6/415
column and then a Sephasil peptide C8 5 μl ST 4.6/250 column. In each round, the
peptide was eluted from the column in a water-2-propanol gradient containing 0.1%
trifluoroacetic acid. The fractions showing the highest specific bacteriocin activity
were pooled and used in subsequent purification steps(Brede, Faye et al. 2004).
In this present work, after removing P. jensenii cells by centrifugation and
membrane filtration (pore size 0.45µm), the bacteriocin jenseniin P were
concentrated by lyophilization. After being resuspended in sodium phosphate buffer,
the sample was dialyzed with a membrane (3.5kDa molecular weight cutoff
membrane) to remove small molecules. An important purification step was the C18
resin silica column, a reverse phase chromatography. Purification steps using
Vivaspin and ammonia sulfate precipitation were evaluated, in which 100kDa and
3kDa molecular weight cutoff membranes and various concentration of ammonia
sulfate were utilized to concentrate and purify jenseniin P.
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2.2 Materials and Methods

2.2.1 Cultures and Media

P. jensenii B1264 and L. delbrueckii subsp. lactis ATCC 4797 were obtained
from Dr. Susan Barefoot, Clemson University, South Carolina. P. acnes 6919 was
purchased from American Type Culture Collection (ATCC, Manassas, VA).
P. jensenii B1264 was cultivated (1% inoculum) in sodium lactate broth (NLB),
consisting of 1% trypticase soy broth without dextrose, 1% yeast extract, and 1%
sodium lactate syrup. Sodium lactate agar (NLA) and soft NLA were prepared by
adding 1.5% or 0.75% agar to NLB, respectively.
L. delbrueckii subsp. lactis ATCC 4797 was cultivated in lactobacilli MRS
broth for 12 hours at 37°C. MRS agar and soft MRS agar were prepared by adding
1.5% or 0.75% agar to MRS broth, respectively.
Frozen stock cultures were maintained at -80°C in the appropriate medium
containing 15% glycerol. Working cultures were prepared from stock cultures by
sub- culturing three times in the appropriate medium.

2.2.2 Bacteriocin Microtiter Plate Assay

Activity of bacteriocin in liquid media was measured in a microtiter plate
assay(Faye, Brede et al. 2002). In brief, each well of the microtiter plate was filled
with 50 μl of a two-fold serial dilution of the antimicrobial sample in NLB or
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sodium phosphate buffer and 150 μl of overnight L. delbrueckii subsp. lactis ATCC
4797 in MRS broth (OD600 = 0.02). The plates were incubated at 37°C for 12 h;
growth inhibition was measured spectrophotometrically at 620 nm with a 96 well
microtiter plate reader. By definition, 1 unit of antimicrobial activity (AU) causes
50% growth inhibition (50% of the turbidity of a control culture without the
peptide)(Faye, Brede et al. 2002). The total antimicrobial unit was defined as the
reciprocal of the highest dilution showing 50% inhibition of the indicator strain and
was expressed in activity unit (AU)/ml.

2.2.3 Bacteriocin Critical Dilution Assay

Bacteriocin activity on plate was measured by the critical dilution
method(Barefoot and Klaenhammer 1984). An MRS agar plate was overlaid with 5
ml soft MRS agar inoculated with 10 μl of overnight MRS broth culture, L.
delbrueckii subsp. ATCC 4797. Serial twofold dilutions of antimicrobial samples
were spotted onto the plate. 1 unit of jenseniin P was defined as the reciprocal of
highest dilution showing clear zones of inhibition and total antimicrobial activity
was expressed in activity units per milliliter (AU/ml).

2.2.4 Total Protein BCA Assay

The Thermo Scientific Micro BCATM Protein Assay Kit (Mfr. No. 23252) was
used to measure total protein. In brief, bovine serum albumin (BSA) was used to
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prepare protein standards. 150 μl of standard or unknown sample was loaded into
microplate wells and 150 μl of the Micro BCA working reagent was added to the
wells and mixed thoroughly on a plate shaker for 30 seconds. The plate was covered
and incubated at 37°C for 2 hours. When the plate cooled down to room temperature,
the absorbance at 570nm was measured on a plate reader. The average 570 nm
absorbance reading of the blank standard was subtracted from all of the other
individual standards and unknown samples. A standard curve was prepared by
plotting the average blank corrected 570nm reading for each BSA standard vs. its
concentration in μg/ml. The standard curve was used to determine the protein
concentration of each unknown sample.

2.2.5 Cultivation of P. jensenii B1264

P. jensenii B1264 was refreshed from frozen culture in -80 ° C and
subcultured two generations on NLA plate and NLB media. After checking purity
with gram stain, the P. jensenii B1264 was inoculated to sodium lactate broth in a 2L
bioreactor anaerobically at 30°C for 18 days. The culture was fed sodium lactate
syrup (60%) twice daily to provide a 0.3% concentration of sodium lactate by
volume. The culture was monitored daily for optical density (600nm), CFU count,
pH, and antimicrobial activity of the supernatant against L. delbrueckii subsp. lactis
ATCC 4797. The antimicrobial activity was measured using the microtiter plate
method. The supernatant was harvested at day 18 for further purification.
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2.2.6 Concentration of Jenseniin P

The culture was centrifuged at 10,000 x g for 30 min at 4°C. The supernatant
was filtered by membrane (pore size 0.45µm). The supernatant was then
concentrated by lyophilization (-80°C, overnight) and was resuspended in 0.05M
sodium phosphate buffer. 1 ml of the sample was dialyzed (3500MWCO membrane)
two times against 12 L of 0.05M sodium phosphate buffer overnight, and the buffer
was changed twice.

2.2.7 C18 Resin Silica Column Purification of Jenseniin P

0.5g C-18 resin silica gel (360130500 Acros Organics) was used to bind protein
from the sample. The protein was eluted from the resin with increasing
concentrations of acetonitrile (015-4 4L Burdick & Jackson) plus trifluoroacetic acid
(TFA) (Sigma T6508 10 Amps). Acetonitrile dilutions were prepared and the sample
volume was increased by dilution with ultrapure distilled H2O (Invitrogen
10977-015). In brief, 0.5g C-18 resin was loaded into a plastic disposable column
(Pierce cat# 29920) and fixed to allow protein binding. First, the column was
washed by adding 5 ml of 5% acetonitrile solution (5% acetonitrile, 94.9% ultrapure
DI H2O, 0.1% TFA), then by 100% acetonitrile solution (99.9% acetonitrile, 0.1%
TFA), and again by 5% acetonitrile solution. Second, a 1 ml sample was loaded onto
the resin and incubated by shaking on an ice bed for 1 hour. Unbound protein from
the column material was eluted by 5 ml of sodium phosphate buffer (0.05M, pH 6.4),
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and elution was collected. Five ml of 10% acetonitrile was used to wash the resin
and the elution was saved in a 15 ml conical screw cap tube. The resin was washed
with 20%, 30%, 40%, 50%, and 100% acetonitrile in the same method and the
samples were collected separately in the appropriately labeled tubes. All samples,
including an unbound sample, 10%, 20%, 30%, 40%, 50%, and 100% acetonitrile
elution samples were frozen to -80 °C then freeze-dried overnight. Freeze-dried
samples were then resuspended in the original volume of sample.

2.2.8 SDS-PAGE Analysis

Three identical 25 μl of partially purified jenseniin P were loaded onto an 18%
SDS-PAGE gel and 10 μl of low-range rainbow molecular weight marker
(Amersham Biosciences, RPN 755) were loaded into a separate lane. The gel was
run at a constant voltage of 100V for 45 min. The gel was then washed in 200 ml of
2.5% Trion X-100 for one hour and then in 200 ml of sterile distilled water for 4 h
with gentle shaking(Miescher, Stierli et al. 2000). The gel was overlaid with 0.75%
soft MRS agar inoculated by L. delbrueckii subsp. lactis ATCC 4797. The gel was
incubated at 37°C overnight. The position of the clear zone of inhibition on the
indicator overlay was compared to that of the marker to determine the molecular
weight of the jenseniin P in the sample.
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2.3 Results and Discussion

2.3.1 Comparison of Two Bacteriocin Bioassay Methods

Jenseniin P was produced in a 2L bioreactor. Five daily samples of supernatant
(day 9, 10, 11, 12, 14) from the second batch of bioreactor samples were assayed
using both the microtiter plate method and the critical dilution method. The results
showed that the sensitivity of the microtiter plate method was 8-fold more sensitive
than the critical dilution method (Fig 2.1).
Both of the method depended on 2-fold dilution of samples. But the microtiter
plate method is more accurate and sensitive because the result was quantified by a
spectrophotometer, while the critical dilution method depended on the evaluation by
naked eyes. One 96-well plate can hold 8 samples while one petri dish can only be
used for one sample. The disadvantage of the microtiter plate method was that at
least 100 μl of sample was required in one single set of assay which was more than
that of the critical dilution method. However, due to the higher sensitivity of the
microtiter plate method, a more diluted sample could be utilized.
In the purification of jenseniin P, the activity of samples after each purification
step was quantified by the microtiter plate method. Because it is convenient,
accurate, and sensitive, meaningful statistical analysis can be carried out.
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2.3.2 Production of Jenseniin P

Four batches of P. jensenii were produced in the bioreator. In the first batch,
OD600, bioactivity against L. delbrueckii, and pH were monitored daily from day 0 to
day 33. The purpose was to determine that when the activity of jenseniin P reached
the maximum. The result showed that the bioactivity became detectable from day 7
in the middle exponential phase and remained stable from day 12 to day 17 in the
early stationary phase and decreased between day 17 and 33, which was from the
middle to late stationary phases (Fig 2.2). In order to harvest active jenseniin P, the
supernatant should be collected near day 17. This result is consistent with
bacteriocin production by other propionibacteria: propionicin T1(Faye, Langsrud et
al. 2000), propionicin SM1(Miescher, Stierli et al. 2000), a precursor protein of an
antimicrobial peptide (PAMP)(Faye, Brede et al. 2002), and propionicin F(Brede,
Faye et al. 2004) are all collected in the late exponential phase or early stationary
phase for further purification. The reason for this result may be that when the
nutrients were limited in the late stationary phase, the bacteriocin was used to inhibit
growth of other competiters, thus the amount of bacteriocin in the supernatant
started to decrease.
In the second batch, the OD600, CFU, bioactivity, and pH were monitored daily.
Since the activity of supernatant reached its maximum level between day 14 and day
17, the supernatant was harvested on day 18 in the second batch(Fig 2.3).
Since the CFU reached its maximum on day 3 and maintained at the same level
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while the OD continued to increase till day 14, it indicated that jenseniin P is
probably produced in middle stationary phase.
In the third batch, on day 5, the bacth culture was found to be contaminated
accornding to result of gram stain (data not shown), because some bacteria did not
show the typical cell morphology of P. jensenii.

The culture could be easily

contaminated since samples were collected daily.
In the fourth batch, the OD, CFU, bioactivity, and pH were monitored daily.
The OD was lower than previous batches and there was no detectable bioactivity
(Fig 2.4). The possible reason was that when single colonies were picked out for
subculturing, the jenseniin P defective cells were picked out and inoculated to the 2L
fermenter. This strain was preserved to be further characterized.
In the cultivation of P. jensenii, sodium lactate syrup was fed into the media
daily instead of one time at the beginning, because the initial high concentration of
sodium lactate has been shown to be toxic to P. jensenii(Wallin 2000). Continuous
culture method was not chosen due to the fact it might keep the bacteria in
exponential phase rather than the stationary phase when the bacteriocin is being
produced.

2.3.3 Purification Result of Jenseniin P

The P. jensenii cells were removed by centrifugation, because activity was
detected in the supernatant. The remaining cells in the supernatant were filtered
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using membrane filtration (pore 0.45 um). The supernatant was then concentrated by
lyophilization and was resuspended in sodium phosphate buffer. The final volume
was adjusted to 1/20 of its original volume. The advantage of lyophilization was that
the temperature was low and it would not denature the protein. Another advantage
was that the sample could be resuspended in any volume with no lost of solute. The
sample was dialyzed to remove soluble constituents and substances with a molecular
weight less than 3.5kDa in the sample.
After dialysis, the sample was loaded to C18 resin silica column for reverse
phase chromatography. During the C18 purification process, each acetonitrile
elution fraction was collected separately. The 50% acetonitrile elution fraction had
the highest activity against L. delbrueckii, while other fractions showed significantly
lower activity (Fig 2.5).
The bioactivity after each purification step was shown (Table 2.1). Compared
with the supernatant of day 18, the specific activity increased 7.81 fold after
lyophilization, and the specific activity increased 19.04 fold in the 50% acetonitrile
elution fraction after C18 resin silica column. The result indicated that the
purification process was effective.

.

After C18 purification, each individual fraction was loaded onto an SDS-PAGE
gel and stained with silver stain. Two prominent bands with molecular weight
ranging from 3.5 to 6.5kDa markers were observed in the 50% acetonitrile elution
fraction (Fig 2.6).
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The principle of C18 reverse phase chromatography purification is based on the
polarity of proteins. When proteins bind to the non-polar C18 matrix, polar proteins
bind loosely while non-polar proteins have high affinity to C18. Since acetonitrile is
a non-polar mobile phase, polar proteins were eluted by lower percentage of
acetonitrile solution, while non-polar proteins were eluted by higher percentage of
acetonitrile. Jenseniin P was mainly eluted in the 50% acetonitrile elution fraction.
In comparison to propionicin T1 and propionicin F, they were eluted using a
continuous mobile gradient(Faye, Langsrud et al. 2000; Brede, Faye et al. 2004). In
order to further purify jenseniin P, subsequent purification process should utilize an
acetonitrile gradient.
In preliminary studies, a Vivaspin method was used in an attempt to concentrate
proteins with a molecular weight between 3 and 100kDa. The problem with
Vivaspin was that the pores in the membrane were easily clogged by large molecules.
Ammonia sulfate solution was also attempted to precipitate jenseniin P. The activity
was detected in 60%, 70% and 80% ammonia sulfate solution, but none of the
fractions showed significant high activity. In comparison, propionicin T1 and
propionicin F had been precipitated by 40% ammonia sulfate solution(Faye,
Langsrud et al. 2000; Brede, Faye et al. 2004). Since the higher the ammonia sulfate
concentration, the stronger the ionic strength, this suggested that jenseniin P was less
polar than propionicin T1 and propionicin F.
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Figure 2.1 Comparison of two bacteriocin bioassays on 5 daily samples, n = 3.
Standard deviations in each daily samples are all zero; the microtiter plate method is
8-fold more sensitive than the critical dilution method. Bracket indicates significant
difference.
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Figure 2.2 The OD, bioactivity, and pH of the first batch of P. jensenii cultivated in a
bioreactor.
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Figure 2.3 The OD, CFU, bioactivity, and pH of the second batch of P. jensenii
cultivated in a bioreactor.
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Figure 2.4 The OD, CFU, bioactivity, and pH of the fourth batch of P. jensenii
cultivated in a bioreactor.
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Figure 2.5 Bioactivity of each acetonitrile elution fraction from C18 resin silica
column. Significant difference from other fractions (*p<0.05). Brackets indicate
significant difference (p<0.05)
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Figure 2.6. Different elution fractions from C18 resin silica column on SDS-PAGE
with silver stain. Lane 1, marker; Lane 2, concentrated jenseniin P; Lane 3, unbound
wash; Lane 4, 10 % acetonitrile elution; Lane 5, 20%; Lane 6, 30%; Lane 7, 40%;
Lane 8, 50%; Lane 9, marker; Lane 10, 100%
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Table 2.1 Purification result of jenseniin P

Supernatant of Day
18
Concentrated
Supernatant
50% elution
Fraction

Purification

Bioactivity

Total Protein

Specific Activity

(AU/ml)

(mg/ml)

(AU/mg)

128±0

6.61±0.75

19.55±2.10

1.00

1877±418

12.86±2.30

152.82±52.15*

7.81

256±0

0.69±0.05

372.23±24.88*

19.04

Factor
(Fold)

*Significant difference from the specific activity of supernatant of day 18
(*p<0.001), n=6.
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CHAPTER THREE

CHARACTERIZATION OF FURTHER PURIFIED JENSENIIN P

3.1 Introduction

The activity of bacteriocin can be affected by different conditions. For example,
temperature can affect the activity of some bacteriocins: at high temperature, the
propionicin PLG-1 loses activity while jenseniin G remains stable(Lyon and Glatz
1991; Grinstead and Barefoot 1992). Some bacteriocins are pH-dependent because
pH

affects

their

net

charge.

For

example,

the

lantibiotic

and

non-lanthionine-containing bacteriocins show higher activity at lower pH (pH 5 and
below) than at physiological pH; their adsorption to the cell surface of
Gram-positive bacteria, including the producing cells is pH-dependent, too(Jack,
Tagg et al. 1995).
Determination of the molecular weight, mode of action, heat stability, and pH
stability of jenseniin P, as well as the inflammatory response tests are the subjects of
this present work.

3.2 Materials and Methods

3.2.1 Enzyme Treatment

Twenty-five μl each of 10mg/ml aqueous solution of trypsin, protease K,
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pronase, protease XIV, lysozyme, and catalase were loaded onto sterilized disks of 7
mm in diameter on MRS agar plates. Twenty-five μl of jenseniin P (50% acetonitrile
elution fraction) was loaded onto another disk next to the disk with enzyme on it.
The distance between the two disks was approximately 1 mm. After 1 hour of
incubation in 37°C, the plate was overlaid with L. delbrueckii in MRS soft agar and
incubated in 37°C for overnight. The clear zones around the disks were evaluated
afterward.

3.2.2 Mode of Action

An overnight culture of L. delbrueckii was centrifuged and resuspended in
0.05M sodium phosphate buffer. OD600 of the suspension was adjusted to 1.0, which
is equivalent to 1.1 x 107 CFU/ml. Five hundred μl of indicator strain and 500 μl of
jenseniin P (50% acetonitrile elution fraction) were mixed and held in 37°C for 60
min. At every 10 min interval, 100 μl samples were obtained from the mixture,
diluted tenfold, and plated out onto MRS agar plates. The reduction in CFU/ml was
recorded.

3.2.3 SDS-PAGE Analysis

Three identical 25 μl of jenseniin P from the 50% acetonitrile elution fraction
were loaded onto three separate lanes of an 18% SDS-PAGE gel, and 10 μl of
low-range rainbow molecular weight marker (Amersham biosciences, RPN 755)
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was loaded into a separate lane. The SDS-PAGE gel ran at a constant voltage of
100V for 45 min. The gel was washed in 200 ml of 2.5% Trion X-100 for 1 h then in
200 ml of sterile distilled water for 4 h at room temperature(Miescher, Stierli et al.
2000). The gel was overlaid with 0.75% soft MRS agar inoculated with L.
delbrueckii subsp. lactis ATCC 4797. The gel was incubated at 37°C for overnight.

3.2.4 Heat Stability

Jenseniin P (50% acetonitrile elution fraction) was held in boiling water in
eppendorf tubes for 90 min. At every 10 min interval, 100 μl of the sample were
taken out and placed on ice. The activity of the sample was measured using the
microtiter plate method.

3.2.5 pH Stability

Twenty μl of concentrated jenseniin P in 0.05 M sodium phosphate buffer (256
AU/ml) or sodium phosphate buffer controls were mixed with 300 μl each of
standard solution with pH of 1, 2, 7, 12, and 13. HCl and NaOH were added into
sterile distilled water to prepare the standard solution.

After mixing, the resulting

pH of the mixtures became 1.9, 4.2, 6.4, 7.0, and 12.8. The mixtures were then
incubated at room temperature for 2 h. The activity of the sample after the treatment
was measured using the microtiter plate method. Two-fold dilutions were made by
using sodium phosphate buffer (pH 6.4).
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3.3 Results and Discussion

3.3.1 Enzyme Treatment

In this present work, activity of jenseniin P was affected by trypsin, protease K,
and pronase; activity of jenseniin P was not affected by protease XIV, lysozyme and
catalase. If the enzyme did not inactivate jenseniin P, a round, clear inhibition zone
around the disks loaded with jenseniin P was observed. Otherwise, one side of the
inhibition zone was smaller than the other side (Fig 3.1). Trypsin cleaves proteins at
the lysine or arginine residues. Protease K is a broad spectrum protease. Pronase can
cause complete digestion of proteins.

3.3.2 Mode of Action of Jenseniin P

Most bacteriocins produced by LAB have a bactericidal mode of
action(Ennahar, Sashihara et al. 2000). Treatment of L. delbrueckii with jenseniin P
caused 99% reduction in the population in 60 min. This result indicated that
jenseniin P has a bactericidal mode of action instead of bacteriostatic; the killing rate
was calculated to be 2.38 log h-1 (Fig 3.2). To further determine whether the killing
activity is bacteriolytic, electro microscopic imaged of jenseniin P treated cells can
be analyzed. In addition, the release of DNA, if any, can be measured by using DNA
gel electrophoresis, SYBR Green nucleic acid stain, or PCR.
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3.3.3 Molecular Weight Determination

After running 45 min in SDS-PAGE gel, the gel was washed with Triton X-100
and distilled water to remove SDS and then overlaid with L. delbrueckii. A clear
zone was formed because jenseniin P inhibited the growth of L. delbrueckii. The
molecular weight was determined to be around 5 kDa. The estimated molecular
weight of 5 kDa is based on comparing the migration distance of the center of the
inhibition zone comparing with the markers using a longer (20cm) SDS-PAGE gel
(data not shown). The shorter (10cm) SDS-PAGE gel was used to demonstrate the
result of the bioassay (Fig3.3) due to the difficulty in photographing large gel. In
previous study, the bioassay was interfered by the presence of SDS in the gel. In this
present work, SDS was removed via washing with Triton X-100 as described in
materials and methods section. As shown in Figure 3.5, the inhibition zone was
pretty tight, which allowed us to accurately determine the molecular weight.
Furthermore, the use of denaturing gel (SDS-PAGE) also allowed us to determine its
true molecular weight, since jenseniin P either was stable to various concentrations
of SDS(Ratnam 1997) or renatured after the Trion X-100 washing step. Although the
use of native gels would allow us to determine the antimicrobial activity, molecular
weight cannot be accurately determined with native gels; mobility in a native gel
matrix depends on both protein charge and hydrodynamic size(Jack, Tagg et al.
1995).
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3.3.4 Heat Stability

In the heat treatment test, the activity of jenseniin P decreased as time increased,
but after treatment in boiling water for 90 minutes, the bioactivity of jenseniin P can
still be detected with an activity of 10 AU/ml (Fig 3.4), approximately a 2-log
reduction over 90 min. In SDS-PAGE analysis, after silver staining, the jenseniin P
band became lighter and lighter from 0 min to 90 min (the band between 3.5 to 6.5
kDa) (Figure 3.5).

3.3.5 pH Stability

Under different pH conditions, jenseniin P exhibited similar activity, which
indicated that the activity of jenseniin P was not affected by pH ranging from 1.9 to
12.8 (Table 3.1). Control groups with L. delbrueckii exposing to the same pH
solutions did not show significant differences in viability, which indicated that the
inhibitory effects observed in the experimental group were caused by jenseniin P, not
by change in pH.
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Figure 3.1. Effect of enzyme treatment on further purified jenseniin P (50 %
acetonitrile elution fraction) Left disks: A. trypsin; B. protease K; C. pronase; D.
protease XIV; E. catalase; F. lysozyme. G&H. MRS broth. Right disks: A-G.
Further purified jenseniin P (50% acetonitrile elution fraction); H. 0.05 M sodium
phosphate buffer.
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Figure 3.2 Killing rate of partially purified jenseniin P (50% acetonitrile elution
fraction) on L. delbrueckii, n=3.
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Figure 3.3 SDS-PAGE and overlay of further purified jenseniin P (50% acetonitrile
elution fraction). Lane 1, 3, and 5 are identical further purified jenseniin P samples;
Lane 10 is marker.
.
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Figure 3.4 Heat treatment of partially purified jenseniin P (50% acetonitrile
elution fraction), n=3.
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Figure 3.5 Effect of heat treatment on further purified jenseniin P (50% acetonitrile
elution fraction)(Lanes 1-8) and concentrated jenseniin P. Lane1, 0 min; Lane 2, 10
min; Lane 3, 20 min; Lane 4, 30 min; Lane5, 40 min; Lane 6, 50 min; Lane 7, 70
min; Lane 8, 90 min; Lane 9, concentrated jenseniin P; Lane10, marker.
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Table 3.1 Effect of pH on activity of jenseniin P
pH of standard

pH of diluted jenseniin P

Activity(AU/ml)

1

1.9

128±0

2

4.2

128±0

7

6.4

128±0

12

7.0

128±0

13

12.8

128±0

solution

No significant difference between different samples.
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CHAPTER FOUR

ANTI-ACNE AGENT PRODUCED BY P. JENSENII B1264

4.1 Introduction

In previous reports, antimicrobial activity of P. jensenii B1264 against L.
delbrueckii ATCC 4797 and P. acnes 6919 was assumed to be due to one agent,
jenseniin P. But according to Klaenhammer, 3%-99% of bacteria and archaea can
produce more than one bacteriocin(Klaenhammer 1988). It is possible that the crude
extract of P. jensenii B1264 contained more than one inhibitory agent. In this present
work, it is determined that jenseniin P, which inhibits the growth of L. delbrueckii, is
not the agent that inhibits the growth of P. acnes 6919.

4.2 Materials and Methods

4.2.1 Bacteriocin Activity Spot Assay Method

For evaluation of bacteriocin activity against L. delbrueckii, 10 ml of 1.5% agar
was poured to form a base layer, and then overlaid with 5 ml soft MRS agar
inoculated with overnight culture of L. delbrueckii in MRS broth (Final OD600 0.02
after inoculation). Ten μl of 10%, 20%, 30%, 40%, 50%, 100% acetonitrile wash, and
unbound fractions were spotted individually onto the top of the plate. The plate was
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then incubated at 37°C for 12 hours.
For evaluation of bacteriocin activity against P. acnes, 10 ml of 1.5 % agar were
poured to form a base layer, and then overlaid with 5 ml soft NLA agar inoculated
with 5 day P. acnes 6919 (Final OD600 0.02 after inoculation). Ten μl of 10%, 20%,
30%, 40%, 50%, 100% acetonitrile wash, and unbound fractions were spotted onto
the top of the plate. The plate was then incubated at 37°C anaerobically for 5 days.

4.3 Results and Discussion

The 50% acetonitrile elution fraction inhibited the growth of L. delbrueckii but
did not inhibit the growth of P. acnes 6919. The 30% acetonitrile elution fraction
inhibited the growth of P. acnes 6919 but did not inhibit the growth of L. delbrueckii
(Fig 4.1).

Prince has already characterized the agent that inhibits the growth of L.

delbrueckii as a bacteriocin, but the agent in the 50% elution that inhibited P. acnes
6919 had not been discovered previously. The agent in the supernatant that inhibited
the growth of P. acnes 6919 could be a metabolite other than a bacteriocin. In order
to prove that such agent is a bacteriocin, its protein nature needs to be confirmed,
and other possibilities need to be excluded. If it is determined to be a bacteriocin in
future work, P. acnes 6919 should be included as an indicator strain in subsequent
purification and characterization processes. The results (Fig 4.1) were reproducible
in triplicate in one batch of C18 resin silica column process.
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Figure 4.1. Spot-on-lawn assay of 50% acetonitrile eluent and 30% acetonitrile
eluent. A. 50% acetonitrile eluent on L. delbrueckii; B. 30% acetonitrile eluent on L.
delbrueckii; C. 50% acetonitrile eluent on P. acnes 6919; D. 30% acetonitrile eluent
on P. acnes 6919.
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CONCLUSIONS

The objective of Prince’s work was to screen for bacteriocins produced by
propionibacteria and she found that the supernatant of P. jensenii B1264 could
inhibit 9 strains of propionibacteria and lactobacillus including itself. Ratnam
partially purified the bacteriocin that could inhibit L. delbrueckii and
characterized it. Ratnam further demonstrated that the partially purified jenseniin
P was also inhibitory to P. acnes. The inhibitory activity to L. delbrueckii and to P.
acnes 6919 was thought to be associated to the same bacteriocin and subsequent
characterizations of jenseniin P were carried out using the L. delbrueckii as an
indicator strain for it ease of cultivation and shorter generation time.
In this present work, we have demonstrated that the bacteriocin which
inhibits the growth of L. delbrueckii is independent from the one that inhibits the
growth of P. acnes 6919. Two independent approaches have been taken for
further characterization of the antimicrobial agents produced by P. jensenii B1264.
In one approach, we further purified the bacteriocin that could inhibit the growth
of L. delbrueckii utilizing C18 resin silica column purification, a reverse phase
chromatography. Additional purification methods could be utilized in future
studies, such as ultra filtration, anion exchange chromatography, gel filtration, and
HPLC or FPLC chromatography. The purified jenseniin P can be sent for
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N-terminal sequencing. Degenerative primers based on the amino acid sequences
can then be synthesized. The gene cluster can be amplified by PCR and the ORFs
in the gene cluster can be analyzed and compared with known bacteriocins.
To localize the DNA region(s) that encodes for jenseniin P gene clusters,
transposon mutagenesis on the whole genome of P. jensenii B1264 could be
utilized. If bacteriocin defective mutants are generated, PCR could be utilized to
amplify the insertion region of the transposon and its flanking sequence. After the
DNA sequence is determined, the amino acid sequence can then be determined.
The difficulty of this method is that, to-date, no transposon mutagenesis have
been conducted with propionibacteria and the only sequenced genome in this
genus is P. acnes.
In this molecular approach, one of the difficulties met by previous colleague
was that the cells of P. jensenii B1264 was difficult to lyse, because the unique
structure of its cell wall. We successfully lysed the cells by using the combination
of 10mg/ml lysozyme and 25 unit/ml mutanolysin, which was the same method
for lysing of P. jensenii DF1 as reported by Miescher(Miescher, Stierli et al.
2000). After lysing the cells, we tried to extract plasmid using Plasmid Mini Kit
(QIAGEN, CA, Cat # 12123), which is designed for extraction of plasmid with a
size range between 10bp and 10kb. However, no plasmid was observed on DNA
agarose gel. The possible reasons might be that there was no or low copy number
plasmids present in the cells, or the size of the plasmids exceeds the capability of
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the plasmid extraction kit. To validate the precious statement, pLME106
containing P. jensenii DF1 strain can be used for the extraction of plasmid. If
pLME106 can be extracted using this kit, then my statement is true. Otherwise, a
more appropriate plasmid extraction method needs to be developed.
In this present work, the results support that jenseniin P is not the agent that
inhibits the growth of P. acnes 6919. If this agent is proved to be a bacteriocin in
the future, it will support the observations that most bacteria and achaea can
produced more than one bacteriocins(Klaenhammer 1988).
In conclusion, we further purified and characterized jenseniin P, mainly via
C18 resin silica column fractionation. Jenseniin P was found to be a small
bacteriocin (3.5-6kDa) with a bactericidal mode of action. In addition, it was
determined to be pH stable and heat stable, because it retains its bactericidal
activity under various pH and after being treated in boiling water for 90 min.
Another important discovery in this research is that P. jensenii B1264 might
produce more than one bacteriocin. Jenseniin P and the agent that inhibit P. acnes
6919 need to be further studied in the future.
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